COVID-19 in Your OPD: Updated Clinical Guidelines for Indian Clinic Doctors (2026)

COVID-19 in India: The 2026 Situation

COVID-19 remains an active health concern in India in 2026, with periodic surges driven by emerging Omicron sub-variants. While the disease is far less severe than in 2020–21 for the vaccinated population, clinic doctors continue to see COVID patients in OPD — both acute cases and patients with persistent post-COVID symptoms.

The current dominant variants are highly transmissible but generally cause milder illness in vaccinated, immunocompetent individuals. However, high-risk groups — elderly, diabetics, immunocompromised patients — still face significant risk of severe disease.

As a clinic doctor, your role has shifted from emergency triage to accurate risk stratification, guided home management, and identifying the minority who need hospital-level care.

Risk Stratification in the OPD

The most important clinical decision you make is whether a COVID patient can be safely managed at home. Use this three-tier framework at every OPD visit:

Home Management Protocol for Low-Risk Patients

For low-risk COVID patients, your prescription and counselling at discharge is what protects them. Cover these five areas clearly:

• Symptom management: Paracetamol 650mg for fever and body ache (avoid NSAIDs in early illness). Throat lozenges, steam inhalation for upper respiratory symptoms. Adequate oral hydration — at least 2–3 litres/day.
• Monitoring: Pulse oximeter reading twice daily, morning and evening. Fever chart maintained by family. Red flag symptoms explained clearly — breathlessness, confusion, SpO2 drop below 94%.
• Rest and nutrition: Complete rest for 5–7 days. High-protein diet. Vitamin C, Zinc, Vitamin D supplementation (evidence supports modest benefit).
• Isolation: Separate well-ventilated room. Mask when in shared spaces. Isolation until 10 days from symptom onset and 24 hours fever-free without antipyretics.
• Follow-up: Teleconsult on day 3 and day 7. Immediate contact if any deterioration.

When to Refer to Hospital: Red Flag Criteria

Send the patient to a hospital emergency immediately if any of the following are present:

• SpO2 below 94% on room air at rest
• Respiratory rate above 24 breaths per minute
• Persistent chest pain or pressure
• Confusion, drowsiness, or altered mental status
• Unable to maintain oral intake or severe dehydration
• Rapidly worsening symptoms over 24 hours
• Pregnancy with moderate or severe symptoms
• Known immunocompromised state with any deterioration

Document the referral reason, vitals at time of referral, and your clinical assessment in the patient's record. If the patient has an ABHA ID, update the encounter so the receiving hospital can access the full history.

Managing Long COVID in Your Clinic

An estimated 10–20% of COVID patients develop Post-Acute Sequelae of COVID-19 (PASC), commonly called long COVID. As a primary care doctor, you will be the first point of contact for these patients — many of whom present months after acute illness with vague, multi-system complaints.

Most common long COVID presentations in Indian OPD:

• Persistent fatigue and post-exertional malaise (most common)
• Brain fog — difficulty concentrating, memory issues
• Breathlessness on exertion despite normal SpO2
• Palpitations and autonomic dysfunction (POTS-like symptoms)
• Joint pains and myalgia
• Sleep disturbance and anxiety
• Hair loss (telogen effluvium — usually resolves in 3–6 months)

Practical approach in OPD: Rule out organic causes first (CBC, thyroid, blood glucose, chest X-ray, ECG for palpitations). Most long COVID symptoms are real but do not have a specific pharmacological fix — the treatment is paced activity, good sleep hygiene, nutritional support, and psychological reassurance. Schedule follow-up appointments at 4–6 week intervals. Maintain a long COVID patient list in your clinic software to ensure continuity of care.

Documentation and ABHA Linking for COVID Patients

Every COVID patient seen in your OPD should have a complete digital record — this matters for continuity of care and for compliance with ABDM guidelines. If your clinic software is ABDM-certified, create or verify the patient's ABHA ID at registration, and push the consultation note — diagnosis (U07.1 or U07.2 ICD-10 code), prescribed medications, and follow-up date — to the patient's ABHA-linked health locker.

This is especially important for moderate-risk patients: if they deteriorate and visit a hospital emergency, the treating team can access your assessment without the patient having to recall medications and dates from memory.

See how CliniqFlo handles COVID patient records with ABDM integration →

Frequently Asked Questions

Should I prescribe ivermectin for COVID patients?

No. ICMR and WHO guidelines do not recommend ivermectin for COVID-19. Multiple randomised controlled trials have shown no benefit. Stick to evidence-based supportive care for mild disease.

How long should a COVID patient be on sick leave?

Minimum 10 days from symptom onset, and at least 24 hours fever-free without antipyretics. Patients with ongoing fatigue or breathlessness may need extended leave — document this clearly in the medical certificate.

Should I test contacts of confirmed COVID patients?

Symptomatic contacts should be tested. Asymptomatic contacts who are high-risk (elderly, immunocompromised) should also be tested. For healthy, vaccinated asymptomatic contacts, testing is optional — watchful waiting with clear red flag instructions is acceptable.

Can COVID patients take their regular medications — metformin, antihypertensives, statins?

Yes. Continue all regular medications unless contraindicated by intercurrent illness (e.g., hold metformin if dehydrated or low oral intake, hold ACE inhibitors if BP drops). Advise patient to monitor BP and glucose more frequently during illness.